Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Sally R Al-Zoubi

1PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Feb 10, 2026
Innovative Drug and Prodrug Candidates in Cancer Treatment Targeting TP53 Mutations: Challenge and Hope.

Raed M Al-Zoubi, Mai Elaarag, Ayman A Zarour

Pageof 1

Frequent Collaborators

1 joint publications

Raed M Al-Zoubi

1 joint publications

Mai Elaarag

1 joint publications

Ayman A Zarour

1 joint publications

Khalil Garada

1 joint publications

Zainab E Fares

1 joint publications

Ahmad R Al-Qudimat

1 joint publications

Mohanad Shkoor

1 joint publications

Mona A Sawali

1 joint publications

Hiba Bawadi

1 joint publications

Zain Z Zakaria

Frequent Collaborators

1 joint publications

Raed M Al-Zoubi

1 joint publications

Mai Elaarag

1 joint publications

Ayman A Zarour

1 joint publications

Khalil Garada

Top Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

12.7K
See more related videos

Top Related Videos

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
13:38

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

12.7K
See more related videos